Cargando…
Hetergeneous tumour response to photodynamic therapy assessed by in vivo localised 31P NMR spectroscopy.
Photodynamic therapy (PDT) is efficacious in the treatment of small malignant lesions when all cells in the tumour receive sufficient drug, oxygen and light to induce a photodynamic effect capable of complete cytotoxicity. In large tumours, only partial effectiveness is observed presumably because o...
Autores principales: | , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1991
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1972526/ https://www.ncbi.nlm.nih.gov/pubmed/1829953 |
_version_ | 1782135024168992768 |
---|---|
author | Ceckler, T. L. Gibson, S. L. Kennedy, S. D. Hill, R. Bryant, R. G. |
author_facet | Ceckler, T. L. Gibson, S. L. Kennedy, S. D. Hill, R. Bryant, R. G. |
author_sort | Ceckler, T. L. |
collection | PubMed |
description | Photodynamic therapy (PDT) is efficacious in the treatment of small malignant lesions when all cells in the tumour receive sufficient drug, oxygen and light to induce a photodynamic effect capable of complete cytotoxicity. In large tumours, only partial effectiveness is observed presumably because of insufficient light penetration into the tissue. The heterogeneity of the metabolic response in mammary tumours following PDT has been followed in vivo using localised phosphorus NMR spectroscopy. Alterations in nucleoside triphosphates (NTP), inorganic phosphate (Pi) and pH within localised regions of the tumour were monitored over 24-48 h following PDT irradiation of the tumour. Reduction of NTP and increases in Pi were observed at 4-6 h after PDT irradiation in all regions of treated tumours. The uppermost regions of the tumours (those nearest the skin surface and exposed to the greatest light fluence) displayed the greatest and most prolonged reduction of NTP and concomitant increase in Pi resulting in necrosis. The metabolite concentrations in tumour regions located towards the base of the tumour returned a near pre-treatment levels by 24-48 h after irradiation. The ability to follow heterogeneous metabolic responses in situ provides one means to assess the degree of metabolic inhibition which subsequently leads to tumour necrosis. IMAGES: |
format | Text |
id | pubmed-1972526 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 1991 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-19725262009-09-10 Hetergeneous tumour response to photodynamic therapy assessed by in vivo localised 31P NMR spectroscopy. Ceckler, T. L. Gibson, S. L. Kennedy, S. D. Hill, R. Bryant, R. G. Br J Cancer Research Article Photodynamic therapy (PDT) is efficacious in the treatment of small malignant lesions when all cells in the tumour receive sufficient drug, oxygen and light to induce a photodynamic effect capable of complete cytotoxicity. In large tumours, only partial effectiveness is observed presumably because of insufficient light penetration into the tissue. The heterogeneity of the metabolic response in mammary tumours following PDT has been followed in vivo using localised phosphorus NMR spectroscopy. Alterations in nucleoside triphosphates (NTP), inorganic phosphate (Pi) and pH within localised regions of the tumour were monitored over 24-48 h following PDT irradiation of the tumour. Reduction of NTP and increases in Pi were observed at 4-6 h after PDT irradiation in all regions of treated tumours. The uppermost regions of the tumours (those nearest the skin surface and exposed to the greatest light fluence) displayed the greatest and most prolonged reduction of NTP and concomitant increase in Pi resulting in necrosis. The metabolite concentrations in tumour regions located towards the base of the tumour returned a near pre-treatment levels by 24-48 h after irradiation. The ability to follow heterogeneous metabolic responses in situ provides one means to assess the degree of metabolic inhibition which subsequently leads to tumour necrosis. IMAGES: Nature Publishing Group 1991-06 /pmc/articles/PMC1972526/ /pubmed/1829953 Text en https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Research Article Ceckler, T. L. Gibson, S. L. Kennedy, S. D. Hill, R. Bryant, R. G. Hetergeneous tumour response to photodynamic therapy assessed by in vivo localised 31P NMR spectroscopy. |
title | Hetergeneous tumour response to photodynamic therapy assessed by in vivo localised 31P NMR spectroscopy. |
title_full | Hetergeneous tumour response to photodynamic therapy assessed by in vivo localised 31P NMR spectroscopy. |
title_fullStr | Hetergeneous tumour response to photodynamic therapy assessed by in vivo localised 31P NMR spectroscopy. |
title_full_unstemmed | Hetergeneous tumour response to photodynamic therapy assessed by in vivo localised 31P NMR spectroscopy. |
title_short | Hetergeneous tumour response to photodynamic therapy assessed by in vivo localised 31P NMR spectroscopy. |
title_sort | hetergeneous tumour response to photodynamic therapy assessed by in vivo localised 31p nmr spectroscopy. |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1972526/ https://www.ncbi.nlm.nih.gov/pubmed/1829953 |
work_keys_str_mv | AT cecklertl hetergeneoustumourresponsetophotodynamictherapyassessedbyinvivolocalised31pnmrspectroscopy AT gibsonsl hetergeneoustumourresponsetophotodynamictherapyassessedbyinvivolocalised31pnmrspectroscopy AT kennedysd hetergeneoustumourresponsetophotodynamictherapyassessedbyinvivolocalised31pnmrspectroscopy AT hillr hetergeneoustumourresponsetophotodynamictherapyassessedbyinvivolocalised31pnmrspectroscopy AT bryantrg hetergeneoustumourresponsetophotodynamictherapyassessedbyinvivolocalised31pnmrspectroscopy |